Disease: Pancreatic carcinoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma 		0.070 Biomarker disease BEFREE SRC and its activated form, phospho-SRC (pSRC), are aberrantly activated in pancreatic cancer and SRC represents a potential target for pancreatic cancer therapy. 30866697 2019
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma 		0.070 Biomarker disease BEFREE Dasatinib is a tyrosine kinase inhibitor, which inhibits tumor proliferation by blocking SRC pathways and is considered as a potential treatment of various epithelial neoplasms, including pancreatic cancer. 31289489 2019
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma 		0.070 Biomarker disease BEFREE STING (or SRC) Like an ICB: Priming the Immune Response in Pancreatic Cancer. 31371279 2019
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma 		0.070 Biomarker disease BEFREE C-Src confers resistance to mitotic stress through inhibition DMAP1/Bub3 complex formation in pancreatic cancer. 30553276 2018
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma 		0.070 Biomarker disease BEFREE Combined targeting of AKT and SRC resulted in a synergistic efficacy against human pancreatic cancer growth and metastasis. 29978609 2018
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma 		0.070 Biomarker disease BEFREE The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion. 24763074 2014
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma 		0.070 Biomarker disease BEFREE Concomitant targeting of EGF receptor, TGF-beta and SRC points to a novel therapeutic approach in pancreatic cancer. 22761868 2012